Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shionogi
Age
0–3
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant who is presenting within 5 days of onset of clinical signs at the time of informed consent.
Participant is diagnosed with RSV within 5 days of sign onset.
Participant's caregiver must be able to complete daily Observer Reported Outcomes (ObsROs) and collect nasal swabs
You may not be if
Participant is hospitalized for reasons other than RSV infection.
Participant is considered by the PI to be immunocompromised, due to an underlying medical condition or medical therapy.
Participant has or has had a confirmed respiratory infection with another clinically relevant viral/bacterial pathogen within 14 days of study enrollment.
Participant underwent major surgery within 28 days prior to enrollment in the study or has planned major surgery within 15 days of expected study completion.
